HWAM
KDNY

Hennion & Walsh Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Hennion & Walsh Asset Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-40,219
Closed -$1.55M – 850
2023
Q2 		$1.55M Buy
40,219
+3,273
+9% +$126K 0.09% 270
2023
Q1 		$855K Buy
36,946
+10,574
+40% +$245K 0.05% 394
2022
Q4 		$691K Buy
+26,372
New +$691K 0.04% 419